Gary M. Pfeiffer has submitted a Form 144, reporting a proposed sale of securities. This filing, dated October 26, 2026, indicates a significant move that could affect his liquidity and the broader implications for the medical laboratory services industry.
Background
Pfeiffer Gary M is associated with Quest Diagnostics Inc, a company in the medical laboratory services sector. The company is identified under the SIC code 8071, which pertains to services in medical laboratories. Recent filings include a Form 4 on May 21, 2026, and another Form 144 on October 22, 2025.
What the Filing Says
Details were not available in the SEC filing.
Impact
This filing may affect Gary M. Pfeiffer's financial position and could influence investor sentiment regarding Quest Diagnostics and its competitors in the medical laboratory services sector.
What's Next
The filing does not say what happens next.
Filing Details
The Form 144 submitted by Gary M. Pfeiffer was accepted by the SEC on the same day it was filed, October 26, 2026, at 9:46:42 AM. This indicates a prompt processing of the report, which is typical for such filings.
Company Information
Quest Diagnostics Inc, the company associated with Gary M. Pfeiffer, is incorporated in Delaware and has a fiscal year ending on December 31. The company operates under the SIC code 8071, which specifically categorizes it within the medical laboratory services sector.
Previous Filings
In addition to the recent Form 144, Gary M. Pfeiffer has a history of regulatory filings, including a Form 4 on May 21, 2026. This previous filing may provide context regarding his trading activities and intentions.
Contact Information
The business and mailing address for Quest Diagnostics is 500 Plaza Drive, Secaucus, NJ 07094, which is also where Gary M. Pfeiffer's correspondence is directed.
What the Filing Does Not Include
The filing does not specify the number of shares Gary M. Pfeiffer intends to sell or the specific reasons behind the proposed sale. Additionally, there is no information regarding any potential impact on the stock price or investor behavior as a result of this filing.